Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 182   

Articles published

PFE 30.40 -0.18 (-0.59%)
price chart
Why I'd Avoid Pfizer Inc. Stock Despite the Dividend
Pfizer's problem in the clinic is uncertainty regarding its ability to generate new blockbuster drugs. The company decided, along with almost every other Big Pharma simultaneously, to go after novel oncology and high cholesterol drugs to replace former ...
Related articles »  
A New Pfizer Inc. Bid For AstraZeneca plc?
Firstly, Pfizer needs to seriously boost its pipeline, and even after such a short time in its refocus plan, AstraZeneca is already seeing results.
Pfizer Inc. (NYSE:PFE) Unlikely to Be Successful with Second Bid for ...  BasicsMedia
Pfizer Inc. (NYSE:PFE) Sets Pace With Palbo Even As The Hunt For Tax ...  FinancialsTrend
Related articles »  
Is It Time to Buy Pfizer Inc.'s Stock?
Since the recession ended, shareholders in Pfizer (NYSE: PFE ) , the world's largest pharmaceutical company by revenue, have seen their shares more than double.
Related articles »  
Interesting January 2015 Stock Options for Pfizer
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer PFE -0.59% Inc (NYSE: PFE). So this week we highlight one interesting put contract, and one interesting call contract, from ...
Related articles »  
Pfizer Inc. (PFE) Tops DJIA Gainers for September 15
The Dow closed at 17,031.10 on Monday, which is a 0.26% move from yesterday's close. Pfizer Inc. led all gainers with a 1.67% jump.
Investors Purchase High Volume of Put Options on Pfizer (PFE)  Watch List News (press release)
Related articles »  
3 Reasons Pfizer Inc.'s Stock Could Fall
Pfizer (NYSE: PFE ) may be the largest pharmaceutical company in the world, but size isn't everything when it comes to developing and selling drugs.
Related articles »  
Pfizer Inc. Trying To Claw Its Way Back Up After Pullback
Do the company's fundamentals call for higher prices? Pfizer shareholders, like so many in the big pharma sector, long for the days of �explosive growth� when the company was releasing its then-new wonder drug, Viagra. Now, it seems as though ...
Active Stocks: Pfizer Inc. (NYSE:PFE), Concur Technologies (NASDAQ:CNQR ...
The Pfizer Inc. (NYSE:PFE) Foundation announced $2 million in grant funding for pilot programs to improve immunization coverage in Africa.
Key Growth Drivers For Pfizer Inc.
ENBREL was released as a co-promotion campaign by Pfizer and Amgen, Inc. (AMGN) last year. Pfizer's rights to ENBREL expired last year, after which it went back to Amgen.
SunTrust Sees Further Pfizer Inc. Bid For AstraZeneca PLC (ADR) 'Highly Likely'
Pfizer Inc. (NYSE: PFE) is likely to boost its offer for British drug maker AstraZeneca PLC (ADR) (NYSE: AZN) to $96.28 a share, an analyst said Tuesday.
AstraZeneca Bullish Options Gain on Pfizer Comeback Bets  Bloomberg
AstraZeneca is tougher Pfizer target as possible bid looms  Bangor Daily News
Related articles »